We are hiring!

Strain identifier

BacDive ID: 5057

Type strain: No

Species: Proteus mirabilis

Strain history: <- ATCC <- FDA, strain PCI 765

NCBI tax ID(s): 584 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 7.1 (current version):
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 7.1 (current version)

General

@ref: 446

BacDive-ID: 5057

DSM-Number: 788

keywords: 16S sequence, Bacteria, aerobe, mesophilic, human pathogen

description: Proteus mirabilis DSM 788 is an aerobe, mesophilic human pathogen of the family Morganellaceae.

NCBI tax id

  • NCBI tax id: 584
  • Matching level: species

strain history: <- ATCC <- FDA, strain PCI 765

doi: 10.13145/bacdive5057.20221219.7.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/pseudomonadota
  • domain: Bacteria
  • phylum: Pseudomonadota
  • class: Gammaproteobacteria
  • order: Enterobacterales
  • family: Morganellaceae
  • genus: Proteus
  • species: Proteus mirabilis
  • full scientific name: Proteus mirabilis Hauser 1885 (Approved Lists 1980)

@ref: 446

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Enterobacteriales, not validated

family: Morganellaceae

genus: Proteus

species: Proteus mirabilis

full scientific name: Proteus mirabilis Hauser 1885

type strain: no

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
446NUTRIENT AGAR (DSMZ Medium 1)yeshttps://mediadive.dsmz.de/medium/1Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water
35612MEDIUM 3 - Columbia agaryesColumbia agar (39.000 g);distilled water (1000.000 ml)
446COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base

culture temp

@refgrowthtypetemperaturerange
446positivegrowth37mesophilic
35612positivegrowth30mesophilic
50915positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

  • @ref: 50915
  • oxygen tolerance: aerobe

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
6837430911sorbitol-builds acid from
6837417057cellobiose-builds acid from
6837417268myo-inositol-builds acid from
6837462345L-rhamnose-builds acid from
6837427082trehalose+builds acid from
6837418333D-arabitol-builds acid from
6837430849L-arabinose-builds acid from
6837417992sucrose-builds acid from
6837417634D-glucose-builds acid from
6837427897tryptophan-energy source
6837415792malonate-assimilation
6837418394palatinose-builds acid from
6837415963ribitol-builds acid from
6837417306maltose-builds acid from
6837416899D-mannitol-builds acid from
68374Potassium 5-ketogluconate-builds acid from
6837418024D-galacturonic acid-builds acid from
6837418403L-arabitol-builds acid from
6837416199urea+hydrolysis
6837425094lysine-degradation
6837429016arginine-hydrolysis
6837418257ornithine+degradation
6836830849L-arabinose-fermentation
6836827613amygdalin-fermentation
6836828053melibiose-fermentation
6836817992sucrose-fermentation
6836862345L-rhamnose-fermentation
6836830911sorbitol-fermentation
6836817268myo-inositol-fermentation
6836816899D-mannitol-fermentation
6836817634D-glucose+fermentation
683685291gelatin-hydrolysis
6836827897tryptophan-energy source
6836816199urea+hydrolysis
6836816947citrate+assimilation
6836818257ornithine+degradation
6836825094lysine-degradation
6836829016arginine-hydrolysis

metabolite production

@refChebi-IDmetaboliteproduction
6837435581indoleno
6836835581indoleno
6836816136hydrogen sulfideno

metabolite tests

@refChebi-IDmetaboliteindole test
6837435581indole-
6836835581indole-

enzymes

@refvalueactivityec
68374L-aspartate arylamidase+3.4.11.21
68374alpha-maltosidase-
68374alpha-galactosidase-3.2.1.22
68374alpha-glucosidase-3.2.1.20
68374beta-galactosidase-3.2.1.23
68374N-acetyl-beta-glucosaminidase-3.2.1.52
68374beta-glucuronidase-3.2.1.31
68374beta-glucosidase-3.2.1.21
68374lipase-
68374urease+3.5.1.5
68374lysine decarboxylase-4.1.1.18
68374arginine dihydrolase-3.5.3.6
68374ornithine decarboxylase+4.1.1.17
68368cytochrome oxidase-1.9.3.1
68368gelatinase-
68368tryptophan deaminase+4.1.99.1
68368urease+3.5.1.5
68368ornithine decarboxylase+4.1.1.17
68368lysine decarboxylase-4.1.1.18
68368arginine dihydrolase-3.5.3.6
68368beta-galactosidase-3.2.1.23

API 20E

@refONPGADH ArgLDC LysODCCITH2SURETDA TrpINDVPGELGLUMANINOSorRHASACMELAMYARAOX
446---++-++---+---------
446---++-++-+-+---------

API ID32E

@refODCADH ArgLDC LysURELARLGAT5KGLIPRPbeta GLUMANMALADOPLEbeta GURMNTINDbeta NAGbeta GALGLUSACLARADARLalpha GLUalpha GALTRERHAINOCELSORalphaMALAspA
50915+--+---------------------+-----+

Safety information

risk assessment

  • @ref: 446
  • pathogenicity human: yes
  • pathogenicity animal: yes
  • biosafety level: 2
  • biosafety level comment: Risk group (German classification)

Sequence information

16S sequences

  • @ref: 20218
  • description: Proteus mirabilis strain ATCC 14153 16S ribosomal RNA gene, partial sequence
  • accession: FJ971887
  • length: 797
  • database: ena
  • NCBI tax ID: 584

External links

@ref: 446

culture collection no.: DSM 788, ATCC 14153, IMET 11232, CCUG 32232, PCI 765

straininfo link

@refpassport
20218http://www.straininfo.net/strains/795400
20218http://www.straininfo.net/strains/16411
20218http://www.straininfo.net/strains/142079

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity8728063An abietane diterpene and two phenolics from Salvia forskahlei.Ulubelen A, Sonmez U, Topcu G, Bozok Johansson CPhytochemistry10.1016/0031-9422(95)00888-81996Anti-Bacterial Agents, Anti-Infective Agents/*chemistry/isolation & purification/pharmacology, Bacillus subtilis/drug effects, Bacteria/*drug effects, Candida albicans/drug effects, Diterpenes/*chemistry/isolation & purification/pharmacology, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Phenols/*chemistry/isolation & purification/pharmacology, Plant Roots, *Plants, Medicinal, Proteus mirabilis/drug effects, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Streptococcus agalactiae/drug effectsEnzymology
Pathogenicity12666252Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl]acetic acid ethyl esters.Ates O, Gursoy A, Altintas H, Otuk G, Birteksoz SArch Pharm (Weinheim)10.1002/ardp.2003900022003Anti-Bacterial Agents/*chemical synthesis/chemistry/pharmacology, Antitubercular Agents/*chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Mycobacterium tuberculosis/*drug effects, Structure-Activity Relationship, Thiazoles/*chemical synthesis/chemistry/pharmacology
Pathogenicity15038463Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities.Ur F, Cesur N, Birteksoz S, Otuk GArzneimittelforschung10.1055/s-0031-12969472004Anti-Infective Agents/*chemical synthesis/*pharmacology, Bacteria/drug effects, Chemical Phenomena, Chemistry, Physical, Fungi/drug effects, Hydrazines/*chemical synthesis/*pharmacology, Indicators and Reagents, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Spectrometry, Mass, Electrospray Ionization, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Thiazoles/*chemical synthesis/*pharmacology
Pathogenicity16129517Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.Koca M, Servi S, Kirilmis C, Ahmedzade M, Kazaz C, Ozbek B, Otuk GEur J Med Chem10.1016/j.ejmech.2005.07.0042005Anti-Infective Agents/*chemical synthesis/chemistry/*pharmacology, Bacteria/drug effects, Benzofurans/*chemical synthesis/chemistry/*pharmacology, Microbial Sensitivity Tests, Molecular Structure, Oximes/*chemical synthesis/chemistry/*pharmacology, Structure-Activity Relationship
Pathogenicity16618017Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2- (5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl) imino-4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships.Altintas H, Ates O, Uyde-Dogan BS, Alp FI, Kaleli D, Ozdemir O, Birteksoz S, Otuk G, Atana D, Uzun MArzneimittelforschung2006Anti-Infective Agents/*chemical synthesis/*pharmacology, Anticonvulsants/*chemical synthesis/*pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Fungi/drug effects, Gas Chromatography-Mass Spectrometry, Indicators and Reagents, Indoles/*chemical synthesis/*pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Pentylenetetrazole/antagonists & inhibitors, Seizures/chemically induced/prevention & control, Spectrometry, Mass, Electrospray Ionization, Spectrophotometry, Infrared, Spectrophotometry, Ultraviolet, Structure-Activity Relationship, Thiazoles/*chemical synthesis/*pharmacology
Pathogenicity21877950Phenolic compounds and biological activity of Kitaibelia vitifolia.Maskovic P, Solujic S, Mihailovic V, Mladenovic M, Cvijovic M, Mladenovic J, Acamovic-Dokovic G, Kurcubic VJ Med Food10.1089/jmf.2011.00132011Anti-Bacterial Agents/*pharmacology, Antifungal Agents/*pharmacology, Aspergillus niger, Bacillus subtilis/drug effects, Candida albicans/drug effects, Escherichia coli/drug effects, Flavonoids/pharmacology, Free Radical Scavengers/*pharmacology, Gallic Acid/pharmacology, Klebsiella pneumoniae/drug effects, Lipid Peroxidation/drug effects, Malvaceae/*chemistry, Microbial Sensitivity Tests, Phenols/*pharmacology, Plant Extracts/*pharmacology, Proteus mirabilis/drug effects, Proteus vulgaris/drug effects, Staphylococcus aureus/drug effects
Pathogenicity23037005Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.Burian A, Erdogan Z, Jandrisits C, Zeitlinger MPharmacology10.1159/0003424232012Amikacin/pharmacology, Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Colistin/pharmacology, Ertapenem, Fosfomycin/pharmacology, Humans, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Trimethoprim/pharmacology, Urine/*chemistry, beta-Lactams/pharmacology

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
446Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 788)https://www.dsmz.de/collection/catalogue/details/culture/DSM-788
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
35612Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/15895
50915Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 32232)https://www.ccug.se/strain?id=32232
68368Automatically annotated from API 20E
68374Automatically annotated from API ID32E